Abstract

In this third and final report in a series, long-time ASQ members and subject matter experts in the pharmaceutical industry offer their insights and reflections regarding the speed, safety, and success with which multiple vaccines were developed to fight COVID-19. Key findings in this case study include the ongoing relevance of Deming’s 14 points, the importance of focusing on patients over profits, and the powerful ways that a culture of quality impacted the outcome of vaccine development initiatives.

ASQ is pleased to offer this article to everyone, regardless of membership status.
Please LOGIN to ASQ's website or create a free account using the REGISTER link in order to download and read. 

.